Skip to main content

Advertisement

Log in

Impaired late suppression of Epstein-Barr virus (EBV)-induced immunoglobulin synthesis: A common feature of autoimmune disease

  • Original Articles
  • Published:
Journal of Clinical Immunology Aims and scope Submit manuscript

Abstract

We examined regulation of Epstein-Barr virus-induced plaque-forming cell generation in peripheral blood mononuclear cells from several autoimmune and seronegative diseases and correlated these results with Epstein-Barr virus-induced proliferation. We confirmed the defective regulation of Epstein-Barr virus-induced plaque-forming cells in peripheral blood mononuclear cells of patients with rheumatoid arthritis and scleroderma. Peripheral blood mononuclear cells from patients with seronegative arthropathies and chronic infective inflammation (cystic fibrosis) had normal regulation of Epstein-Barr virus-induced plaque-forming cells. Peripheral blood mononuclear cells from rheumatoid arthritis had excessive plaque-forming cell generation in the face of a normally regulated decrease in Epstein-Barr virus-induced proliferation. In contrast, peripheral blood mononuclear cells from scleroderma had defective suppression of both Epstein-Barr virus-induced proliferation and plaque-forming cell generation. Thus, impaired regulation of Epstein-Barr virus-induced plaque-forming cell generation is a common feature of autoimmune disease and demonstrates some specificity for these disorders.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Tosato P, Magrath IT, Blaese M: T-cell mediated immunoregulation of Epstein Barr virus (EBV) B-lymphocyte activation in EBV-seropositive and EBV-seronegative individuals. J Immunol 128:575–579, 1982

    Google Scholar 

  2. Alspaugh MA, Jensen FC, Robin H, Tan EM: Lymphocytes transformed by Epstein-Barr virus: induction of nuclear antigen reactive with antibody in rheumatoid arthritis. J Exp Med 147:1018–1027, 1978

    Google Scholar 

  3. Alspaugh MA, Henle G, Lennetle ET, Henle W: Elevated levels of antibodies to Epstein-Barr virus antigens in sera and fluids of patients with rheumatoid arthritis. J Clin Invest 67:1134–1140, 1976

    Google Scholar 

  4. Depper JM, Bluestein HG, Zvaifler NJ: Impaired regulation of Epstein-Barr virus induced outgrowth in rheumatoid arthritis is due to a T-cell defect. J Immunol 127:1899–1902, 1981

    Google Scholar 

  5. Tosato G, Steinberg AD, Blaese RM: Defective EBV-specific suppressor T-cell function in rheumatoid arthritis. N Engl J Med 305:1238–1243, 1981

    Google Scholar 

  6. Tsokos GC, Magrath IT, Balow JE: Epstein-Barr virus induces normal B-cell responses but defective suppressor T-cell responses in patients with systemic lupus erythematosus. J Immunol 131:1797–1801, 1983

    Google Scholar 

  7. Kahan A, Kahan A, Menkes CJ, Amor B: Defective Epstein-Barr virus specific suppressor T-cell function in progressive systemic sclerosis. Ann Rheum Dis 45:553–560, 1986

    Google Scholar 

  8. Ropes MWG, Bennett GA, Cobb S,et al.: Revision of diagnostic criteria for rheumatoid arthritis. Arth Rheum 2:517–524, 1951

    Google Scholar 

  9. Masi AT, Rodnan GP, Medsger TA,et al.: Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arth Rheum 23:581–590, 1980

    Google Scholar 

  10. Bennett PH, Burch TA: New York symposium on population studies in rheumatic diseases: New diagnostic criteria. Bull Rheum Dis 17:453–458, 1967

    Google Scholar 

  11. Tan PLJ, Shore A: Thymosin induces helper function in OKT3-positive, E-rosette negative human cord blood T-cells. Scand J Immunol 20:27–35, 1984

    Google Scholar 

  12. Burns GF, Pike BL: Spontaneous reverse haemolytic plaque formation. J Immunol Methods 41:269–277, 1981

    Google Scholar 

  13. Tan PLJ, Pang G, Wilson D: Immunoglobulin productionin vitro by peripheral blood lymphocytes in systemic lupus erythematosus: Helper T-cell defect and B-cell hyperreactivity. Clin Exp Immunol 44:548–554, 1981

    Google Scholar 

  14. Tan PLJ, Pang G, Cullinaue G, Wilson, D: Immunoglobulin-secreting cells in SLE: Correlation with disease activity. J Rheumatol 7:807–813, 1980

    Google Scholar 

  15. Bardwick PA, Bluestein HG, Zvaifler NJ,et al.: Altered regulation of Epstein-Barr virus induced lymphoblast proliferation in rheumatoid arthritis lymphoid cells. Arth Rheum 23:626–631, 1980

    Google Scholar 

  16. Stierle HE, Brown KA, Perry JD, Holborrow EJ: Increased responsiveness of rheumatoid B-lymphocytes to stimulation by Epstein-Barr virus. Rheumatol Int 3:7–11, 1983

    Google Scholar 

  17. Tan PLJ, Shore A: Two separate mechanisms for the feedback suppression of immunoglobulin production: Epstein-Barr virus induced B lymphoblastoid cell lines activate suppressor T-cells and enhance γ-interferon production. Arth Rheum 27:S56, 1984 (abstr)

    Google Scholar 

  18. Hasler F, Bluestein WG, Zvaifler NJ, Epstein LB: Analysis of the defects responsible for the impaired regulation of Epstein-Barr virus-induced B-cell proliferation by rheumatoid arthritis lymphocytes. J Exp Med 157:173–188, 1983

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Shore, A., Klock, R., Lee, P. et al. Impaired late suppression of Epstein-Barr virus (EBV)-induced immunoglobulin synthesis: A common feature of autoimmune disease. J Clin Immunol 9, 103–110 (1989). https://doi.org/10.1007/BF00916937

Download citation

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00916937

Key words

Navigation